Biochemistry and Diseases Related to the Interconversion of Phosphatidylcholine, Phosphatidylethanolamine, and Phosphatidylserine.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Supplement × Supplement·Evidence index
PubMed indexes 7 records that name Phosphatidylcholine and Phosphatidylserine together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.
Every statement below is attributed to a named, dated, linked source.
This page lists published research relevant to Phosphatidylcholine and Phosphatidylserine. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.
Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
“IMS analysis for lipid species such as phosphatidylcholine and phosphatidylserine allows researchers to pinpoint areas of lipid deficiencies or accumulations associated with ocular disorders such as age-related macular degeneration and diabetic retinopathy. Here, we describe an end-to-end IMS approach from sample preparation to data analysis for phosphatidylcholine and phosphatidylserine analysis.”
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Names both Phosphatidylcholine and Phosphatidylserine in its title.
Names Phosphatidylcholine and Phosphatidylserine together in an interaction, co-administration, or pharmacokinetic context.
Search-based evidence indexes have real limits, and it is worth being explicit about them:
NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Phosphatidylcholine, Phosphatidylserine, and several hundred other substances.
The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.